Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene

about

Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene

Item

http://www.wikidata.org/entity/Q40461808

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical Courses of Two Pediat ...... the CBFA2T3-GLIS2 Fusion Gene

@en

type

Item

label

Clinical Courses of Two Pediat ...... the CBFA2T3-GLIS2 Fusion Gene

@en

prefLabel

Clinical Courses of Two Pediat ...... the CBFA2T3-GLIS2 Fusion Gene

@en

P1476

Clinical Courses of Two Pediat ...... the CBFA2T3-GLIS2 Fusion Gene

@en

P2093

Fumiko Tanaka

http://www.w3.org/2001/XMLSchema#string

Fuminori Iwasaki

http://www.w3.org/2001/XMLSchema#string

Hiroaki Goto

http://www.w3.org/2001/XMLSchema#string

Hiromi Kato

http://www.w3.org/2001/XMLSchema#string

Koji Sasaki

http://www.w3.org/2001/XMLSchema#string

Masakatsu D Yanagimachi

http://www.w3.org/2001/XMLSchema#string

Masanobu Takeuchi

http://www.w3.org/2001/XMLSchema#string

Mayu Ishibashi

http://www.w3.org/2001/XMLSchema#string

Ryosuke Kajiwara

http://www.w3.org/2001/XMLSchema#string

Shin-Ichi Tsujimoto

http://www.w3.org/2001/XMLSchema#string

P2860

The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia.

Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.

An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia.

Clinicopathological characteristics of extramedullary acute megakaryoblastic leukemia (AMKL): report of a case with initial mastoid presentation and review of literature to compare extramedullary AMKL and non-AMKL cases.

DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia.

Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.

The expression of the CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia.

CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.

Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.

CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype.

P304

331-334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4274/TJH.2016.0008

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Reo Tanoshima

P577

2016-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27094503

http://www.w3.org/2001/XMLSchema#string

P932

5204189

http://www.w3.org/2001/XMLSchema#string